In a scandal that rocked Japan's scientific establishment, Riken -- the research institute that sponsored the study -- launched an independent experiment in April to verify research published by scientist Haruko Obokata and her colleagues earlier this year.
But the failure to replicate the experiment casts further doubt on the existence of stem cell-like cells, what the researchers called Stimulus-Triggered Acquisition of Pluripotency (STAP) cells.
"Researchers have conducted 22 experiments thus far, but we could not confirm the emergence of cells in the conditions described in (Obokata's) papers," Riken said in an interim report issued today.
The researchers will continue their experiments under more diverse conditions while also considering data obtained by Obokata herself, Shinichi Aizawa, a special adviser at Riken, told a lengthy press conference.
Obokata was feted after unveiling findings that appeared to show a straightforward way to re-programme adult cells to become stem cells -- precursors that are capable of developing into any other cell in the human body.
Identifying a readily manufacturable supply of stem cells could one day help meet a need for transplant tissues, or even whole organs, meaning that any advance in the field is met with excitement in the scientific community.
Leading science journal Nature withdrew the flawed stem-cell study after Obokata agreed in June to retract the papers.
Nature said it would tighten procedures to vet future studies submitted for publication.
It said the decision was taken after mistakes were discovered in some data published in two papers, photograph captions were found to be misleading, and the work itself could not be repeated by other scientists.
Earlier this month Obokata's co-author, stemcell scientist Yoshiki Sasai, hanged himself, further shaking Japan's scientific establishment.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
